Related references
Note: Only part of the references are listed.Patterns of Cannabis Use in Patients With Cyclic Vomiting Syndrome
Thangam Venkatesan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Hepatocyte-stellate cell synapse in alcohol-induced steatosis: another role for endocannabinoids
Josepmaria Argemi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Actionable biomarkers: the key to resolving disorders of gastrointestinal function
Michael Camilleri et al.
GUT (2020)
OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) - PRECLINICAL AND EARLY CLINICAL DEVELOPMENT
Beatriz F. Lindstrom et al.
GASTROENTEROLOGY (2019)
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial
Daniel G. Couch et al.
INFLAMMATORY BOWEL DISEASES (2019)
Su1930 – Safety and Efficacy of Olorinab, a Peripherally Restricted, Highly Selective, Cannabinoid Receptor 2 Agonist in a Phase 2A Study in Chronic Abdominal Pain Associated with Crohn’s Disease
Bruce Yacyshyn et al.
GASTROENTEROLOGY (2019)
Sa1738 – Olorinab (Formerly Apd371), a Peripherally Restricted, Highly Selective, Full Agonist of the Cannabinoid Receptor 2 (CB2), Reduces Visceral Hypersensitivity in Animal Models
Joel Castro et al.
GASTROENTEROLOGY (2019)
Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
Ivonne Bazwinsky-Wutschke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
μ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients
Giovanni Dothel et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis
Won-Mook Choi et al.
CELL METABOLISM (2019)
Relationship Between Recreational Marijuana Use and Bowel Function in a Nationwide Cohort Study
Adeyinka Charles Adejumo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Effects of Medical Cannabis on Use of Opioids and Hospital Visits by Patients With Painful Chronic Pancreatitis
Trevor S. Barlowe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016
Kelly C. Young-Wolff et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Cannabis, Cannabinoids, and the Endocannabinoid SystemIs there Therapeutic Potential for Inflammatory Bowel Disease?
Tim Ambrose et al.
JOURNAL OF CROHNS & COLITIS (2019)
Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH)
S. Nordmann et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Cyclic vomiting syndrome is a prevalent and under-recognized condition in the gastroenterology outpatient clinic
R. C. Sagar et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Cannabinoids for nausea and vomiting related to chemotherapy: Overview of systematic reviews
Victor Schussel et al.
PHYTOTHERAPY RESEARCH (2018)
The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice
Hongbo Li et al.
CELLULAR IMMUNOLOGY (2018)
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis
Peter M. Irving et al.
INFLAMMATORY BOWEL DISEASES (2018)
Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans
M. Camilleri
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Cannabis use during pregnancy: Pharmacokinetics and effects on child development
Kimberly S. Grant et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Marijuana Use in Pregnancy and While Breastfeeding
Torri D. Metz et al.
OBSTETRICS AND GYNECOLOGY (2018)
Role of cannabis in digestive disorders
Hemant Goyal et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B
Erhei Dai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Unintentional Cannabis Ingestion in Children: A Systematic Review
John R. Richards et al.
JOURNAL OF PEDIATRICS (2017)
Pharmacologic Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review
John R. Richards et al.
PHARMACOTHERAPY (2017)
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
Aviv M. Weinstein et al.
FRONTIERS IN PSYCHIATRY (2017)
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis
Howard Meng et al.
ANESTHESIA AND ANALGESIA (2017)
Review: The Role of Cannabinoids on Esophageal Function-What We Know Thus Far
Jonathan Gotfried et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study
Marjan de Vries et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial
Timna Naftali et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery
David Neville Levin et al.
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2017)
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome
C. Cremon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial
Mathieu Cote et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2016)
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
Robert J. Tait et al.
CLINICAL TOXICOLOGY (2016)
The Role of the Endocannabinoid System in the Brain-Gut Axis
Keith A. Sharkey et al.
GASTROENTEROLOGY (2016)
Nabilone for the Management of Pain
Corey C. Tsang et al.
PHARMACOTHERAPY (2016)
Cannabinoid Receptor Agonist Namisol Does Not Affect Cytokine Levels In Chronic Pancreatitis Patients
Wesley K. Utomo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation
M. Bashashati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH)
Maria Patrizia Carrieri et al.
CLINICAL INFECTIOUS DISEASES (2015)
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
Alexandra Weiss et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
From the Bench, Toward the Clinic: Therapeutic Opportunities for Cannabinoid Receptor Modulation
Robert P. Picone et al.
MOLECULAR ENDOCRINOLOGY (2015)
Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome
F. Cristofori et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohn's Disease
Martin Storr et al.
INFLAMMATORY BOWEL DISEASES (2014)
Decreased enteric fatty acid amide hydrolase activity is associated with colonic inertia in slow transit constipation
Shu-Cheng Zhang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol/high fat diet induced pancreatitis
Liping Zhang et al.
MOLECULAR PAIN (2014)
Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study
Timna Naftali et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy
Sarah C. Preissner et al.
PLOS ONE (2013)
Cannabinoid Hyperemesis: A Case Series of 98 Patients
Douglas A. Simonetta et al.
MAYO CLINIC PROCEEDINGS (2012)
Localization of mGluR5, GABAB, GABAA, and cannabinoid receptors on the vago-vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study
W. O. Rohof et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2012)
Effect of rimonabant on oesophageal motor function in man
E. Scarpellini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
Rongrong Jiang et al.
LIFE SCIENCES (2011)
Hepatitis C Virus Induces the Cannabinoid Receptor 1
David van der Poorten et al.
PLOS ONE (2010)
Distinct Effects of Delta 9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Paolo Fusar-Poli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans
H. Beaumont et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats
Marnie Duncan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
K. L. Wright et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet
V. Di Marzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The endocannabinoid system and liver diseases
P. Caraceni et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity
Akira Kikuchi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Novel cannabinoid receptors
A. J. Brown
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis
Christoph W. Michalski et al.
GASTROENTEROLOGY (2007)
Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study
T. Esfandyari et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon
Nicholas M. Hinds et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell
P Juan-Picó et al.
CELL CALCIUM (2006)
Review article: endocannabinoids and their receptors in the enteric nervous system
M Duncan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C
C Hézode et al.
HEPATOLOGY (2005)
The endogenous cannabinoid system protects against colonic inflammation
F Massa et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Involvement of cannabinoid receptors in gut motility and visceral perception
PJ Hornby et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse
JH Allen et al.
GUT (2004)
Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain
DJ Buggy et al.
PAIN (2003)
Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease
Q Zhang et al.
GUT (2002)
Share Paper
